Industry Specific Issues

R&D Tax 2012 Lodgement Deadline: Information for Companies

April 12th, 2013

30 April 2013 is the lodgement deadline for companies wishing to claim eligible R&D tax 2012 year under the new R&D Tax Incentive. Companies planning to submit 2012 claims should be compiling submissions NOW to ensure Applications are prepared to an adequate standard. Below are some key issues companies and their tax agents should be mindful of for 2012 R&D claims under the new Incentive: The base rate of recoupment has increased to provide tax savings of $0.15 and $0.10 for companies […]

Read More

Prana Biotechnology in Melbourne has received $5.8 million for clinical research for neurological diseases

April 10th, 2013

Melbourne company Prana Biotechnology has announced it has received a R&D Tax Incentive of A$2.5 million to support its scientific focus upon neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. The payment is part of approximately A$5.8 million which is expected to be received for the 2011-12 and 2012-13 financial years. “This Australian Government funded program is commendable because it provides significant amounts of non-dilutive cash to support our ongoing research activities.” commented Geoffrey Kempler, Prana’s Chairman and CEO.

Read More

Swanson Reed appear in The Australian Financial Review

August 14th, 2012

You can also read the online version here.

Read More

Email this job

[recaptcha]